Literature DB >> 24209972

Model for concomitant microdialysis sampling of the pons and cerebral cortex in rhesus macaques (Macaca mulatta).

Cynthia M McCully1, Devang Pastakia, John Bacher, Marvin L Thomas, Emilie A Steffen-Smith, Kadharbatcha Saleem, Robert F Murphy, Stuart Walbridge, Lauren Brinster, Brigitte C Widemann, Katherine E Warren.   

Abstract

Pediatric diffuse intrinsic pontine gliomas are aggressive brainstem tumors that fail to respond to treatment. We hypothesize that the protective features of the pons may hinder chemotherapeutic agents from entering pontine tissue compared with cortical brain tissue. To test this hypothesis, we developed a unique nonhuman primate model using microdialysis, a continuous in vivo extracellular sampling technique, to compare drug exposure concurrently in pontine tissue, cortical tissue, CSF, and plasma after intravenous administration of chemotherapeutic agents. The surgical coordinates and approach for microdialysis cannula-probe placement were determined in 5 adult male rhesus monkeys (Macaca mulatta) by using MRI. Microdialysis cannulas-probes were implanted stereotactically in the brain, retrodialysis was performed to measure relative recovery, and a 1-h intravenous infusion of temozolomide was administered. Continuous microdialysis samples were collected from the pons and cortex over 4 h with concurrent serial plasma and CSF samples. Postsurgical verification of microdialysis cannula-probe placement was obtained via MRI in 3 macaques and by gross pathology in all 5 animals. The MRI-determined coordinates and surgical methodologies resulted in accurate microdialysis probe placement in the pons and cortex in 4 of the 5 macaques. Histologic examination from these 4 animals revealed negligible tissue damage to the pontine and cortical tissue from microdialysis. One macaque was maintained for 8 wk and had no deficits attributed to the procedure. This animal model allows for the determination of differences in CNS penetration of chemotherapeutic agents in the pons, cortex, and CSF after systemic drug administration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24209972      PMCID: PMC3750672     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  8 in total

1.  Probe calibration in transient microdialysis in vivo.

Authors:  P M Bungay; R L Dedrick; E Fox; F M Balis
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples.

Authors:  D Scheller; J Kolb
Journal:  J Neurosci Methods       Date:  1991-11       Impact factor: 2.390

3.  Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates.

Authors:  Mahendra Patel; Cynthia McCully; Karen Godwin; Frank M Balis
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

Review 4.  OsiriX: an open-source software for navigating in multidimensional DICOM images.

Authors:  Antoine Rosset; Luca Spadola; Osman Ratib
Journal:  J Digit Imaging       Date:  2004-06-29       Impact factor: 4.056

5.  Zidovudine concentration in brain extracellular fluid measured by microdialysis: steady-state and transient results in rhesus monkey.

Authors:  Elizabeth Fox; Peter M Bungay; John Bacher; Cynthia L McCully; Robert L Dedrick; Frank M Balis
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

6.  Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus.

Authors:  Y Wang; S L Wong; R J Sawchuk
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

7.  Cerebral subarachnoid sampling of cerebrospinal fluid in the rhesus monkey.

Authors:  J D Bacher; F M Balis; C L McCully; K S Godwin
Journal:  Lab Anim Sci       Date:  1994-04

8.  Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors.

Authors:  Holly J Meany; Katherine E Warren; Elizabeth Fox; Diane E Cole; Alberta A Aikin; Frank M Balis
Journal:  Cancer Chemother Pharmacol       Date:  2009-05-09       Impact factor: 3.333

  8 in total
  4 in total

1.  Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models.

Authors:  Cynthia Lester McCully; Louis T Rodgers; Rafael Cruz; Marvin L Thomas; Cody J Peer; William D Figg; Katherine E Warren
Journal:  Neurooncol Adv       Date:  2020-01-01

Review 2.  Intersection of Brain Development and Paediatric Diffuse Midline Gliomas: Potential Role of Microenvironment in Tumour Growth.

Authors:  Katie F Loveson; Helen L Fillmore
Journal:  Brain Sci       Date:  2018-11-16

Review 3.  Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma.

Authors:  Katherine Elizabeth Warren
Journal:  Front Oncol       Date:  2018-07-03       Impact factor: 6.244

Review 4.  Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors.

Authors:  Rianne Haumann; Jessica Carvalho Videira; Gertjan J L Kaspers; Dannis G van Vuurden; Esther Hulleman
Journal:  CNS Drugs       Date:  2020-09-23       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.